The Stanley Family Foundation announced another $280 million for the Stanley Center for Psychiatric Research at Broad Institute earlier this month, bringing its total contributions to the Massachusetts-based nonprofit over $1 billion.
The funds raised through Visionaries of the Year are used for research to advance lifesaving therapies like immunotherapy, genomics and personalized medicine, which are saving lives today.
According to the patent, a specific crystalline form of the drug known as polymorph C may be more effective than other versions because it is absorbed more efficiently by the body. The patent also notes that laboratory studies showed the drug reduced tumor growth and helped mice with brain tumors live longer, prompting early clinical trials to test whether the treatment is safe and effective in humans.
Scientists are increasingly turning to artificial-intelligence systems for help drafting the grant proposals that fund their careers, but preliminary data indicate that these tools might be pulling the focus of research towards safe, less-innovative ideas. These data provide evidence that AI-assisted proposals submitted to the US National Institutes of Health (NIH) are consistently less distinct from previous research than ones written without the use of AI - and are also slightly more likely to be funded.
The Trump administration has reportedly slashed U.S. federal funding for mental health and addition programs, a move that experts say will exacerbate the country's already acute drug crisis. The loss could total some $2 billion in grants from the Substance Abuse and Mental Health Services Administration (SAMHSA), NPR reported, citing unnamed sources. But the extent of the cuts has not been verified. The number of grants canceled could be as high as 2,800, according to STAT.
Brugge and her research team have analyzed the cell structure of more than 100 samples. Using high-powered microscopes and complex computer algorithms, they diagram each stage in the development of breast cancer: from the first sign of cell mutation to the formation of tiny clusters, well before they are large enough to be considered tumors. Their quest is to prevent breast cancer, a disease that afflicts roughly 1 in 8 U.S. women over their lifetimes, as well as some men.
I'm certainly confident that we're going to have a breakthrough within my career, and I have a good 10 to 15 years left. While antiretroviral (ARV) therapies are extending lives and keeping HIV at bay, and PrEP has the potential to effectively halt transmission of the virus, a cure has remained elusive. That's because the HIV virus itself is elusive, both co-opting the immune system and hiding from it.
At the end of January, Washington, DC, saw an extremely unusual event. The MAHA Institute, which was set up to advocate for some of the most profoundly unscientific ideas of our time, hosted leaders of the best-funded scientific organization on the planet, the National Institutes of Health. Instead of a hostile reception, however, Jay Bhattacharya, the head of the NIH, was greeted as a hero by the audience, receiving a partial standing ovation when he rose to speak.
For nearly 100 years, the United States has been the world's leader in a wide variety of scientific fields. No other country has: invested as much in fundamental scientific research, has made more scientific breakthroughs and scientific advances, has attracted more scientific researchers to move there to conduct their research, or has conducted more projects and been home to more scientists that have won Nobel Prizes.
Laboratories turned to a smart workaround when COVID‑19 testing kits became scarce in 2020. They mixed samples from several patients and ran a single test. If the test came back negative, everyone in it was cleared at once. If it was positive, follow-up tests would zero in on who was infected. That strategy, known as group testing, saved valuable time, money, and resources.